Home
>
National Drug Code (NDC)
>
HyperHEP B S/D
HyperHEP B S/D - 13533-636-02 - (Hepatitis B Immune Globulin (Human))
Drug Information of HyperHEP B S/D
| Product NDC: | 13533-636 |
| Proprietary Name: | HyperHEP B S/D |
| Non Proprietary Name: | Hepatitis B Immune Globulin (Human) |
| Active Ingredient(s): | 220 [iU]/mL & nbsp; Hepatitis B Immune Globulin (Human) |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of HyperHEP B S/D
| Product NDC: | 13533-636 |
| Labeler Name: | Grifols Therapeutics Inc. |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA101146 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19961009 |
Package Information of HyperHEP B S/D
| Package NDC: | 13533-636-02 |
| Package Description: | 1 SYRINGE, GLASS in 1 CARTON (13533-636-02) > 1 mL in 1 SYRINGE, GLASS (13533-636-20) |
NDC Information of HyperHEP B S/D
| NDC Code | 13533-636-02 |
| Proprietary Name | HyperHEP B S/D |
| Package Description | 1 SYRINGE, GLASS in 1 CARTON (13533-636-02) > 1 mL in 1 SYRINGE, GLASS (13533-636-20) |
| Product NDC | 13533-636 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | Hepatitis B Immune Globulin (Human) |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 19961009 |
| Marketing Category Name | BLA |
| Labeler Name | Grifols Therapeutics Inc. |
| Substance Name | HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN |
| Strength Number | 220 |
| Strength Unit | [iU]/mL |
| Pharmaceutical Classes | Human Immunoglobulin [EPC],Passively Acquired Immunity [PE],Virus Neutralization [MoA],Virus-specific Hyperimmune Globulins [Chemical/Ingredient],Immunoglobulins [Chemical/Ingredient] |
